Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Bicycle Therap. - encouraging in ovarian

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Sep 08, 2022 11:48am

120 Views

Post# 34949560

RE:RE:RE:RE:RE:Bicycle Therap. - encouraging in ovarian

I ran out of patience some time ago, however, my wife has been graciously lending me some of her seemingly unlimited supply of patience, especially when it comes to me.

Note to Thera, Pleeezzz get us above the penny stock range before my 2022 RMD is due as I sure would hate to be forced to sell at this SP.